NextGen Healthcare (NXGN) Tops Q1 EPS by 13c, Revenues Beat

NextGen Healthcare (NASDAQ: NXGN) reported Q1 EPS of $0.21, $0.13 better than the analyst estimate of $0.08. Revenue for the quarter came in at $130.9 million versus the consensus estimate of $114.38 million.

“In the face of unprecedented conditions, NextGen delivered an exceptional performance by minimizing revenue impact, preserving earnings, and generating free cash when patient visit volume was significantly reduced,” said Rusty Frantz, president and chief executive officer of NextGen Healthcare. “As we move through the quarter, our attention has turned back to innovation, commercial execution, and growth based on our differentiated, future-facing ambulatory platform that is purpose built to engage patients in their wellness journey.”

Fiscal 2021 Financial Outlook

Given the continued uncertainty in the market, the Company is not providing annual guidance. As the market stabilizes and there is more confidence in the macro environment, the Company will evaluate returning to guidance.

For earnings history and earnings-related data on NextGen Healthcare (NXGN) click here.

You May Also Be Interested In

• IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
• Altria Group (MO) Reports In-Line Q1 EPS, Offers FY24 EPS Guidance
• Bristol-Myers Squibb (BMY) tops Q1 earnings, revenue estimates; FY guidance updated